Loading asset research
Xilio Therapeutics Inc. Common Stock
XLONasdaq · USD · StocksQuote as of · Exchange session not verified$8.93
0.00%
Today
XLO
Loading 1D prices…
Market cap
$58.8M
Volume
5.1K
52w high
$12.7452w low
$6.47Company profile
Xilio Therapeutics Inc. Common Stock
Xilio Therapeutics, Inc., a clinical-stage biotechnology company, engages in the discovery and development of masked immuno-oncology therapies. The company's pipeline includes XTX501, a bispecific PD-1 / masked IL-2, for patients with metastatic non-small cell lung cancer; Efarindodekin alfa, an investigational, masked IL-12, that is in Phase 2 clinical trial for patients with advanced solid tumors; and Vilastobart, an investigational tumor-activated, Fc-enhanced, high affinity binding anti-CTLA-4 monoclonal antibody. The company was founded in 2016 and is headquartered in Waltham, Massachusetts.
Sector
Health Care
Industry
Pharmaceutical Preparations
Exchange
Nasdaq
Display currency
USD
Location
WALTHAM, MA, United States
Employees
76
Fiscal year end
1231
CIK
1840233
Session & valuation
Open$8.93
Previous close$8.93
Day high$9.49
Day low$8.93
30-day avg. volume11.8K
Outstanding shares5.8M
Diluted EPS-$4.19
Latest annual period
P/E (trailing)-2.13
P/E (forward)-15.40
Price / book1.15
Beta-0.12
Dividend yield—
Deterministic peer set
Companies with SEC SIC 2834
Exact regulatory industry matches, ranked by nearest market capitalization.
| Company | Market cap | Revenue | Net margin | Diluted EPS | Today | Consensus |
|---|---|---|---|---|---|---|
| HRTXHeron Therapeutics Inc. Common Stock | $59.9M | $154.9M | -12.91% | -$0.12 | -1.47% | Hold |
| SERSerina Therapeutics Inc. Common Stock | $56.4M | $130K | -14755.38% | -$1.91 | -8.00% | Buy |
| HYFTMindWalk Holdings Corp. Common Stock | $61.3M | — | — | -$0.31 | -1.14% | Hold |
| IMMPImmutep Limited American Depositary Shares | $55M | — | — | -$0.539 | +12.12% | Hold |
| HYPDHyperion DeFi Inc. Common Stock | $54.2M | $813.5K | -5570.56% | -$9.40 | -3.20% | Hold |